A Multi-center, Open-label, Single-arm Phase II/III Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To 65 Years with Newly-diagnosed Philadelphia-Negative ALL

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT04817761

Study #:
STUDY00149068

Start Date:
Apr 17, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04817761

View Complete Trial Details & Eligibility at ClinicalTrials.gov